Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Australia Says Tamiflu Use To Remain Restricted For H1N1

This article was originally published in PharmAsia News

Executive Summary

Australia's health minister cautioned the public against using Roche's Tamiflu (oseltamivir) for the H1N1 influenza virus now declared a global pandemic. Health Minister Nicola Roxon said the drug would not be prescribed for most cases of the swine flu, particularly not for mild cases. High demand already is restricting commercial supplies, she said, but the government still has stockpiles of the drug available. She also said the World Health Organization declaration of a pandemic would not necessarily change Australia's handling of H1N1. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC071881

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel